Contemporary surgical management of hypertrophic cardiomyopathy, the need for more myectomy surgeons and disease-specific centers, and the tufts initiative

American Journal of Cardiology

Volumn 112, Issue 9, 2013, Pages 1512-1515

  Maron, Barry J ^a   Rastegar, Hassan ^b   Udelson, James E ^b   Dearani, Joseph A ^c   Maron, Martin S ^b  

^a MINNEAPOLIS HEART INSTITUTE FOUNDATION   (United States)

^b TUFTS MEDICAL CENTER   (United States)

^c MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALCOHOL;

DEFIBRILLATOR; GOLD STANDARD; HEART CATHETERIZATION; HEART FAILURE; HEART LEFT VENTRICLE PRESSURE; HEART VENTRICLE SEPTUM DEFECT; HUMAN; HYPERTROPHIC CARDIOMYOPATHY; MITRAL VALVE REPAIR; MUSCLE RESECTION; NEW YORK HEART ASSOCIATION CLASS; PACEMAKER; PATIENT CARE; PATIENT REFERRAL; PERCUTANEOUS CORONARY INTERVENTION; PRIORITY JOURNAL; REJUVENATION; REVIEW; SUDDEN DEATH; SURGICAL MORTALITY; SYMPTOM; TRANSCATHETER AORTIC VALVE IMPLANTATION;

EID: 84885953631     PISSN: 00029149     EISSN: 18791913     Source Type: Journal    
DOI: 10.1016/j.amjcard.2013.06.040     Document Type: Editorial

References (33)

1. B.J. Maron, and M.S. Maron Hypertrophic cardiomyopathy Lancet 381 2013 242 255
2. B.J. Maron, W.J. McKenna, G.K. Danielson, L.J. Kappenberger, H.J. Kuhn, C.E. Seidman, P.M. Shah, W.H. Spencer, P. Spirito, F.J. ten Cate, and E.D. Wigle American College of Cardiology/European Society of Cardiology clinical expert consensus document on hypertrophic cardiomyopathy. A report of the American College of Cardiology Task Force on Clinical Expert Consensus Documents and the European Society of Cardiology Committee for Practice Guidelines committee to Develop an expert consensus Document on hypertrophic cardiomyopathy J Am Coll Cardiol 42 2003 1687 1713 Eur Heart J 2003;24:1965-1991
3. B.J. Gersh, B.J. Maron, R.O. Bonow, J.A. Dearani, M.A. Fifer, M.S. Link, S.S. Naidu, R.A. Nishimura, S.R. Ommen, H. Rawkowski, C.E. Seidman, J.A. Towbin, J.E. Udelson, and C.W. Yancy 2011 ACCF/AHA guideline for the diagnosis and treatment of hypertrophic cardiomyopathy: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines Circulation 124 2011 e783 e831 J Am Coll Cardiol 2011;58:e212-e260
4. B.J. Maron Controversies in cardiovascular medicine. Surgical myectomy remains the primary treatment option for severely symptomatic patients with obstructive hypertrophic cardiomyopathy Circulation 116 2007 196 206
5. R.A. Nishimura, and S.R. Ommen Septal reduction therapy for obstructive hypertrophic cardiomyopathy and sudden death: what statistics cannot tell you Circ Cardiovasc Interv 3 2010 91 93
6. B.J. Maron Commentary and re-appraisal: surgical septal myectomy vs. alcohol ablation: after a decade of controversy and mismatch between clinical practice and guidelines Prog Cardiovasc Dis 54 2012 523 528
7. M.H. Yacoub Surgical versus alcohol septal ablation for hypertrophic obstructive cardiomyopathy: the pendulum swings Circulation 112 2005 450 452
8. R.A. Leonardi, E.P. Kransdorf, D.L. Simel, and A. Wang Meta-analyses of septal reduction therapies for obstructive hypertrophic cardiomyopathy: comparative rates of overall mortality and sudden cardiac death after treatment Circ Cardiovasc Interv 3 2010 97 104
9. P. Sorajja, S.R. Ommen, D.R. Holmes Jr., J.A. Dearani, C.S. Rihal, B.J. Gersh, R.J. Lennon, and R.A. Nishimura Survival after alcohol septal ablation for obstructive hypertrophic cardiomyopathy Circulation 126 2012 2374 2380
10. S.R. Ommen, B.J. Maron, I. Olivotto, M.S. Maron, F. Cecchi, S. Betocchi, B.J. Gersh, M.J. Ackerman, R.B. McCully, J.A. Dearani, H.V. Schaff, G.K. Danielson, A.J. Tajik, and R.A. Nishimura Long-term effects of surgical septal myectomy on survival in patients with obstructive hypertrophic cardiomyopathy J Am Coll Cardiol 46 2005 470 476
11. S. Argawal, E.M. Tuzcu, M.Y. Desai, N. Smedira, H.M. Lever, B.W. Lytle, and S.R. Kapadia Updated meta-analysis of septal alcohol ablation versus myectomy for hypertrophic cardiomyopathy J Am Coll Cardiol 55 2010 823 834
12. P. Sorajja, U. Valeti, R.A. Nishimura, S.R. Ommen, C.S. Rihal, B.J. Gersh, D.O. Hodge, H.V. Schafff, and D.R. Holmes Outcome of alcohol septal ablation for obstructive hypertrophic cardiomyopathy Circulation 118 2008 131 139
13. H.D. Schulte, W.H. Bircks, B. Loesse, E.A. Godehardt, and B. Schwartzkopff Prognosis of patients with hypertrophic obstructive cardiomyopathy after transaortic myectomy. Late results up to twenty-five years J Thorac Cardiovasc Surg 106 1993 709 717
14. B.J. Maron, J.A. Dearani, S.R. Ommen, M.S. Maron, H.V. Schaff, B.J. Gersh, and R.A. Nishimura The case for surgery in obstructive hypertrophic cardiomyopathy J Am Coll Cardiol 44 2004 2044 2053
15. A.G. Morrow, B.A. Reitz, S.E. Epstein, W.L. Henry, D.M. Conkle, S.B. Itscoitz, and D.R. Redwood Operative treatment in hypertrophic subaortic stenosis. Techniques, and the results of pre and postoperative assessments in 83 patients Circulation 52 1975 88 102
16. A. Woo, W.G. Williams, R. Choi, E.D. Wigle, E. Rozenblyum, K. Fedwick, S. Siu, A. Ralph-Edwards, and H. Rakowski Clinical and echocardiographic determinants of long-term survival after surgical myectomy in obstructive hypertrophic cardiomyopathy Circulation 111 2005 2033 2041
17. W. Ball, J. Ivanov, H. Rakowski, E.D. Wigle, M. Linghorne, A. Ralph-Edwards, W.G. Williams, L. Schwartz, A. Guttman, and A. Woo Long-term survival in patients with resting obstructive hypertrophic cardiomyopathy comparison of conservative versus invasive treatment J Am Coll Cardiol 58 2011 2313 2321
18. A. Iacovoni, P. Spirito, C. Simon, M. Iascone, G. Di Dedda, P. De Filippo, S. Pentiricci, L. Boni, M. Senni, A. Gavazzi, and P. Ferrazzi A contemporary European experience with surgical septal myectomy in hypertrophic cardiomyopathy Eur Heart J 33 2012 2080 2087
19. N.G. Smedira, B.W. Lytle, H.M. Lever, J. Rajeswaran, G. Krishnaswamy, R.K. Kaple, D.O. Dolney, and E.H. Blackstone Current effectiveness and risks of isolated septal myectomy for hypertrophic obstructive cardiomyopathy Ann Thorac Surg 85 2008 127 133
20. S.E. Altarabsheh, J.A. Dearani, H.M. Burkhart, H.V. Schaff, S.V. Deo, B.W. Eidem, S.R. Ommen, Z. Li, and M.J. Ackerman Outcome of septal myectomy for obstructive hypertrophic cardiomyopathy in children and young adults Ann Thorac Surg 95 2013 663 669
21. B.J. Maron, M. Yacoub, and J.A. Dearani Controversies in cardiovascular medicine. Benefits of surgery for obstructive hypertrophic cardiomyopathy: bring septal myectomy back for European patients Eur Heart J 32 2011 1055 1058
22. B.J. Maron Surgery for hypertrophic obstructive cardiomyopathy: alive and quite well Circulation 111 2005 2016 2018
23. B.J. Maron, S.R. Ommen, R.A. Nishimura, and J.A. Dearani Myths about surgical myectomy: rumors of its death have been greatly exaggerated Am J Cardiol 101 2008 887 889
24. K. Minakata, J.A. Dearani, R.A. Nishimura, B.J. Maron, and G.K. Danielson Extended septal myectomy for hypertrophic obstructive cardiomyopathy with anomalous mitral papillary muscles or chordae J Thorac Cardiovasc Surg 127 2004 481 489
25. B.J. Maron, M.S. Maron, E.D. Wigle, and E. Braunwald The 50-year history, controversy, and clinical implications of left ventricular outflow tract obstruction in hypertrophic cardiomyopathy: from idiopathic hypertrophic subaortic stenosis to hypertrophic cardiomyopathy J Am Coll Cardiol 54 2009 191 200
26. F.J. ten Cate, O.I. Soliman, M. Michels, D.A. Theuns, P.L. de Jong, M.L. Geleijnse, and P.W. Serruys Long-term outcome of alcohol septal ablation in patients with obstructive hypertrophic cardiomyopathy: a word of caution Circ Heart Fail 3 2010 362 369
27. I. Olivotto, S.R. Ommen, M.S. Maron, F. Cecchi, and B.J. Maron Surgical myectomy versus alcohol septal ablation for obstructive hypertrophic cardiomyopathy. Will there ever be a randomized trial? J Am Coll Cardiol 50 2007 831 834
28. M.S. Maron, B.J. Maron, C. Harrigan, J. Buros, C.M. Gibson, I. Olivotto, L. Biller, J.R. Lesser, J.E. Udelson, W.J. Manning, and E. Appelbaum Hypertrophic cardiomyopathy phenotype revisited after 50 years with cardiovascular magnetic resonance J Am Coll Cardiol 54 2009 220 228
29. H.G. Klues, W.C. Roberts, and B.J. Maron Anomalous insertion of papillary muscle directly into anterior mitral leaflet in hypertrophic cardiomyopathy. Significance in producing left ventricular outflow obstruction Circulation 84 1991 1188 1197
30. B.J. Maron, R.A. Nishimura, and G.K. Danielson Pitfalls in clinical recognition and a novel operative approach for hypertrophic cardiomyopathy with severe outflow obstruction due to anomalous papillary muscle Circulation 98 1998 2505 2508
31. R.O. Bonow, B.A. Carabello, C. Kanu, A.C. de Leon Jr., D.P. Faxon, M.D. Freed, W.H. Gaasch, B.W. Lytle, R.A. Nishimura, P.T. O'Gara, R.A. O'Rourke, C.M. Otto, P.M. Shah, J.S. Shanewise, S.C. Smith Jr., A.K. Jacobs, C.D. Adams, J.L. Anderson, E.M. Antman, D.P. Faxon, V. Fuster, J.L. Halperin, L.F. Hiratzka, S.A. Hunt, B.W. Lytle, R. Nishimura, R.L. Page, and B. Riegel ACC/AHA 2006 guidelines for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (writing committee to revise the 1998 Guidelines for the Management of Patients with Valvular Heart Disease): developed in collaboration with the Society of Cardiovascular Anesthesiologists: endorsed by the Society for Cardiovascular Angiography and Interventions and the Society of Thoracic Surgeons Circulation 114 2006 e84 e231
32. B.J. Maron Hypertrophic cardiomyopathy centers Am J Cardiol 104 2009 1158 1159
33. F.G. Bakaeen, B. Kar, D. Chu, L.D. Cornwell, A. Blaustein, G.N. Levine, D. Paniagua, H. Jneid, C. Jensen, P.V. Atluri, C.F. Bechara, P. Kougias, C. Pawlak, B. Bozkurt, T.A. Burdon, and B.A. Carabello Establishment of a transcatheter aortic valve program and heart valve team at a Veterans Affairs facility Am J Surg 204 2012 643 648